Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Martin, Bögemann"'
Autor:
David Ventura, Philipp Rassek, Philipp Schindler, Burak Han Akkurt, Linus Bredensteiner, Martin Bögemann, Katrin Schlack, Robert Seifert, Michael Schäfers, Wolfgang Roll, Kambiz Rahbar
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Prostate-specific membrane antigen positron emission tomography (PSMA-PET) is an essential tool for patient selection before radioligand therapy (RLT). Interim-staging with PSMA-PET during RLT allows for therapy monitoring. Howeve
Externí odkaz:
https://doaj.org/article/df3f1ee603084bb3b65b7c49acbc1e64
Autor:
Simon Lange, Anna Kuntze, Neele Wüstmann, Theresa Reckers, Verena Humberg, Wilhelm G. Dirks, Sebastian Huss, Julia Vieler, Andres Jan Schrader, Martin Bögemann, Katrin Schlack, Christof Bernemann
Publikováno v:
Biological Research, Vol 57, Iss 1, Pp 1-13 (2024)
Abstract Background Research on prostate cancer is mostly performed using cell lines derived from metastatic disease, not reflecting stages of tumor initiation or early progression. Establishment of cancer cell lines derived from the primary tumor si
Externí odkaz:
https://doaj.org/article/9adb8406bc7c41b0aaacef4df2b2900e
Autor:
Viktor, Grünwald, Martin, Bögemann, Mohammad-Reza, Rafiyan, Günter, Niegisch, Marco, Schnabel, Anne, Flörcken, Michael, Maasberg, Christoph, Maintz, Mark-Oliver, Zahn, Anke, Wortmann, Andreas, Hinkel, Jochen, Casper, C, Darr, Thomas, Hilser, M, Schulze, Disorn, Sookthai, Philipp, Ivanyi
Publikováno v:
In Clinical Genitourinary Cancer October 2024 22(5)
Autor:
Neele Wüstmann, Konstantin Seitzer, Verena Humberg, Julia Vieler, Norbert Grundmann, Julie Steinestel, Dorothee Tiedje, Stefan Duensing, Laura-Maria Krabbe, Martin Bögemann, Andres Jan Schrader, Christof Bernemann, Katrin Schlack
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-14 (2023)
Abstract Background Androgen receptor (AR) splice variants (AR-Vs) have been discussed as a biomarker in prostate cancer (PC). However, some reports question the predictive property of AR-Vs. From a mechanistic perspective, the connection between AR
Externí odkaz:
https://doaj.org/article/2099e95770b44143932183ee7f6b5264
Autor:
Katrin Schlack, Konstantin Seitzer, Neele Wüstmann, Verena Humberg, Norbert Grundmann, Julie Steinestel, Dorothee Tiedje, Kambiz Rahbar, Laura-Maria Krabbe, Martin Bögemann, Andres J. Schrader, Christof Bernemann
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Biomarker in metastatic castration resistant prostate cancer (mCRPC) treatment are rare. We aimed to compare the clinical value of circulating tumor cells (CTCs) and androgen receptor splice variant 7 (AR-V7) as biomarker in mCRPC patients u
Externí odkaz:
https://doaj.org/article/68fc05281a2f455ba029b1959b708c40
Autor:
Steffen Lebentrau, Gamal Anton Wakileh, Martin Schostak, Hans-Peter Schmid, Rodrigo Suarez-Ibarrola, Axel S. Merseburger, Georg C. Hutterer, Ulrike H. Necknig, Michael Rink, Martin Bögemann, Luis Alex Kluth, Armin Pycha, Maximilian Burger, Sabine D. Brookman-May, Johannes Bründl, Matthias May
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPenile cancer represents a rare malignant disease, whereby a small caseload is associated with the risk of inadequate treatment expertise. Thus, we hypothesized that strict guideline adherence might be considered a potential surrogate for t
Externí odkaz:
https://doaj.org/article/c1376d782de048189d86ed4a5b3c2f01
Autor:
Annemarie Uhlig, Johannes Uhlig, Michael Woike, Thomas Fischer, Lutz Trojan, Lothar Bergmann, Martin Bögemann, Peter J. Goebell, Michael Rink, Katrin Schlack, Marianne Leitsmann, Arne Strauß
Publikováno v:
Kidney Cancer. :1-12
Objective: To evaluate the effectiveness and safety profile of the tyrosine kinase inhibitor Axitinib for patients with advanced or metastatic renal cell carcinoma (a/mRCC) in a real-world setting. Methods: Adult patients from the German non-interven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb01df865a420f1aad736639a9bfc20b
https://doi.org/10.3233/kca-220011
https://doi.org/10.3233/kca-220011
Autor:
Evan Y. Yu, Michael P. Kolinsky, William R. Berry, Margitta Retz, Loic Mourey, Josep M. Piulats, Leonard J. Appleman, Emanuela Romano, Gwenaelle Gravis, Howard Gurney, Martin Bögemann, Urban Emmenegger, Anthony M. Joshua, Mark Linch, Srikala Sridhar, Henry J. Conter, Brigitte Laguerre, Christophe Massard, Xin Tong Li, Charles Schloss, Christian H. Poehlein, Johann S. de Bono
Publikováno v:
European Urology. 82:22-30
Patients with metastatic castration-resistant prostate cancer (mCRPC) frequently receive docetaxel after they develop resistance to abiraterone or enzalutamide and need more efficacious treatments.To evaluate the efficacy and safety of pembrolizumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa4643d037afae5e03bf2fb4cc807f9
https://doi.org/10.1016/j.eururo.2022.02.023
https://doi.org/10.1016/j.eururo.2022.02.023
Autor:
Dianne van Strijp, Christiane de Witz, Birthe Heitkötter, Sebastian Huss, Martin Bögemann, George S. Baillie, Miles D. Houslay, Chris Bangma, Axel Semjonow, Ralf Hoffmann
Publikováno v:
Prostate Cancer, Vol 2019 (2019)
Objectives. To investigate the added value of assessing transcripts for the long cAMP phosphodiesterase-4D (PDE4D) isoforms, PDE4D5 and PDE4D9, regarding the prognostic power of the ‘CAPRA & PDE4D7’ combination risk model to predict longitudinal
Externí odkaz:
https://doaj.org/article/2a81cda05f6f4790873f44fc52c19088
Autor:
Martin Bögemann, Gaetano Facchini, Thomas Bauernhofer, Richard Cathomas, Evanguelos Xylinas, Bertrand Tombal
Publikováno v:
Irish Journal of Medical Science (1971 -).
Background Patients with advanced prostate cancer have a poor prognosis, and well-tolerated new treatment strategies are required to improve survival outcomes. Apalutamide is a novel androgen signalling inhibitor developed to be used in combination w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e742072ed4f3f98c5ce52744ab9204a
https://doi.org/10.1007/s11845-023-03303-y
https://doi.org/10.1007/s11845-023-03303-y